BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million BMY will pay BBIO $90 million in upfront cash. 2 MIN READ 05.12.2022
KKR Beats Estimates With 63% Increase in After-Tax Distributable Earnings Henry Kravis and his peers have been selling assets for top dollar as the global economy bounces back from fallout of the COVID-19 pandemic. 2 MIN READ 05.4.2021
